James David Clark Cvs Health Corp (CVS) insider trading activity

James David Clark is SVP, Cont & Chief Acct Officer of CVS HEALTH Corp. Currently has a direct ownership of 8,480 shares of CVS, which is worth approximately $505,408. The most recent transaction as insider was on Apr 01, 2024, when has been sold 3,004 shares (Common Stock) at a price of $79.56 per share, resulting in proceeds of $238,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.48K

18.6% 3M change

72.16% 12M change

Total Value Held $505,408

James David Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Payment of exercise price or tax liability	$238,998 $79.56 p/Share	3,004 Reduced 26.16%	8,480 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$849,939 $79.56 p/Share	10,683 Added 41.42%	15,109 Common Stock (restricted)
Feb 12 2024	BUY Grant, award, or other acquisition	-	2,452 Added 25.54%	7,150 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$8,354 $68.48 p/Share	122 Reduced 1.37%	8,760 Common Stock (restricted)
Aug 03 2023	SELL Open market or private sale	$1,928,576 $74.87 p/Share	25,759 Reduced 84.57%	4,698 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$109,310 $74.31 p/Share	1,471 Reduced 4.61%	30,457 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	$162,441 $74.31 p/Share	2,186 Added 19.4%	9,080 Common Stock (restricted)

Feb 28 2023	SELL Payment of exercise price or tax liability	$14,953 $83.54 p/Share	179 Reduced 0.68%	26,151 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$15,552 $101.65 p/Share	153 Reduced 0.58%	26,177 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$670,934 $101.09 p/Share	6,637 Reduced 20.13%	26,330 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	$324,903 $101.09 p/Share	3,214 Added 20.04%	12,824 Common Stock (restricted)
Feb 28 2022	SELL Payment of exercise price or tax liability	$45,191 $103.65 p/Share	436 Reduced 1.61%	26,668 Common Stock
Feb 21 2022	BUY Grant, award, or other acquisition	-	8,595 Added 24.78%	26,092 Common Stock
Jan 28 2022	SELL Open market or private sale	$660,431 $109.0 p/Share	6,059 Reduced 25.72%	17,497 Common Stock
Jan 28 2022	BUY Exercise of conversion of derivative security	$619,593 $102.26 p/Share	6,059 Added 20.46%	23,556 Common Stock
Dec 01 2021	SELL Payment of exercise price or tax liability	$6,037 $88.78 p/Share	68 Reduced 0.4%	16,921 Common Stock (restricted)
Apr 03 2021	SELL Payment of exercise price or tax liability	$35,664 $74.3 p/Share	480 Reduced 2.67%	17,497 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$501,451 $74.3 p/Share	6,749 Reduced 28.51%	16,920 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	$349,953 $74.3 p/Share	4,710 Added 20.7%	18,046 Common Stock (restricted)
Mar 31 2021	SELL Open market or private sale	$406,600 $76.0 p/Share	5,350 Reduced 42.48%	7,244 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$397,452 $74.29 p/Share	5,350 Added 29.81%	12,594 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$76,919 $68.13 p/Share	1,129 Reduced 13.48%	7,244 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	13,113 Added 42.24%	17,930 Common Stock
May 26 2020	SELL Open market or private sale	$17,550 $65.0 p/Share	270 Reduced 5.61%	4,547 Common Stock
Apr 28 2020	SELL Open market or private sale	$405,210 $65.0 p/Share	6,234 Reduced 56.41%	4,817 Common Stock

JDC

James David Clark

SVP, Cont & Chief Acct Officer

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Value

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS

Account